Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,572 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07522671Recruiting
3D-Printed Crowns and Bridges for Dental Implants
This trial compares two types of artificial tooth restorations (made from resin or zirconia) placed on dental implants that have already fused with your jawbone. The study tests how well these 3D-printed restorations work and last over time.
Shibīn al KawmAges 18–60 - NCT06306456RecruitingPhase 1/Phase 2
GH21 combined with osimertinib for advanced lung cancer
This trial tests a new drug (GH21) combined with the targeted therapy osimertinib (Tagrisso) for people with advanced non-small cell lung cancer that has an EGFR mutation and has stopped responding to a similar treatment. The goal is to see if the combination can help when the cancer has progressed.
Hefei, AnhuiAges 18 years+ - NCT06447753Recruiting
Comparing two treatments for tooth pain in back molars
This study compares two ways to treat a deep cavity in a back molar that has a moderately inflamed nerve. If you have a painful deep cavity, this trial will test if a partial or complete nerve treatment works better to save your tooth.
Rohtak, HaryanaAges 18–60 - NCT07706192Recruiting
Food assistance for cancer patients facing hunger
This trial tests whether providing food assistance helps cancer patients stick to their treatment plan and improve their health. It is for patients who sometimes or often worry about having enough food to eat.
Richmond, VirginiaAges 18 years+ - NCT06292208RecruitingPhase 1/Phase 2
Testing IBD0333 for advanced solid tumors or lymphoma
This trial tests an experimental drug called IBD0333 for people with advanced solid tumors or lymphoma who have run out of standard options. The drug targets a protein called 4-1BB to help your immune system fight cancer.
Jinan, ShandongAges 18–80 - NCT07704333RecruitingPhase 1
PET scan test for mold infections
This study is testing a new imaging agent to see if it can help detect invasive mold infections in the body. It will involve healthy volunteers and people with certain types of fungal infections.
Bethesda, MarylandAges 18–100 - NCT07704320Recruiting
Testing the BreathAlert device for apnea monitoring
This trial tests a device called BreathAlert that monitors breathing and detects when a patient stops breathing (apnea). It aims to help doctors and nurses keep a closer watch on patients who are at risk.
BlantyreAges birth–17 years - NCT07269145RecruitingPhase 1
Testing TQB3122 capsules in advanced solid tumors
This trial tests an experimental oral capsule (TQB3122) for safety and early signs of effectiveness in people with advanced solid tumors that have not responded to standard therapies. It is for patients who are relatively healthy and have specific cancer types like ovarian, breast, or prostate cancer.
Beijing, Beijing MunicipalityAges 18–75 - NCT07504029Recruiting
Test if bitter melon peptides help control blood sugar
This trial is studying peptides from bitter melon (Momordica charantia) to see if they can help manage blood sugar levels in people with prediabetes. You may be eligible if you have higher-than-normal blood sugar but not full diabetes.
TaichungAges 30–65 - NCT06990126Enrolling by invitation
New tetracycline for drug-resistant bacterial infections
This trial tests a new tetracycline antibiotic (neotetracycline) for treating infections caused by drug-resistant Gram-negative bacteria. It aims to see how well the drug works and what side effects it may have.
Nanjing, JiangsuAges 18 years+ - NCT06483256Recruiting
Outcomes after surgery for biceps tendon injury
This study looks at how well patients do after surgery for a biceps tendon injury, using a specific surgical technique. It may help you understand what results to expect if you have had this type of surgery.
BolognaAges 18 years+ - NCT05699226Recruiting
Testing whether adjusting ECT treatment helps depression outcomes
This study tests a way of adjusting (titrating) ECT treatment to improve outcomes in people with major depression or bipolar II. It’s mainly for those who already need ECT with right-side electrode placement.
Albuquerque, New MexicoAges 50 years+ - NCT07025304Recruiting
Study of REFLEX ULTRA 45 for nasal turbinate reduction in China
This trial tests a new device called REFLEX ULTRA 45 that uses radiofrequency energy to shrink the nasal turbinates (the fleshy shelves inside your nose) to help you breathe easier. It is for people with long-term nasal stuffiness who have not gotten relief from nasal sprays.
Guangzhou, GuangdongAges 18–65 - NCT07181876Recruiting
Study of robotic hernia repair with Dexter system
This study tests a robotic system for fixing groin hernias (inguinal hernias) using small incisions. It is for adults scheduled for hernia repair surgery who want to see how well the robot helps.
Buffalo, New YorkAges 22 years+ - NCT06158477RecruitingPhase 1
A study of JYP0035 for advanced solid tumors
This trial tests a new drug called JYP0035 alone in people with advanced solid tumors. It aims to see if the drug is safe and effective.
Shanghai, Shanghai MunicipalityAges 18–74 - NCT06958627RecruitingPhase 2/Phase 3
Smart phone app vs standard care for breast cancer treatment
This trial tests whether a smartphone-based patient management program helps women with HER2-positive breast cancer take their medication (pyrotinib) more consistently compared to usual care. It may be a good fit if you are starting or continuing pyrotinib treatment.
Beijing, Beijing MunicipalityAges 18 years+ - NCT05970016RecruitingPhase 1/Phase 2
Study for advanced solid cancers with a DNA repair target
This Phase I/II trial tests an investigational treatment in people with advanced solid tumors that have grown despite standard therapy, or where standard options aren’t available. In later Phase II, the trial mainly enrolls patients whose tumor shows a specific DNA repair problem (DDR defect).
Beijing, Beijing MunicipalityAges 18–70 - NCT07677722Recruiting
Comparing two types of partial knee replacements
This trial compares two designs of partial knee replacements (fixed bearing vs mobile bearing) to see which offers better results and fewer problems for people with arthritis in the inner part of the knee. If you meet the criteria, this study might help you and your doctor choose the best option.
Ieper, Oost-VlaanderenAges 50–80 - NCT07712523RecruitingPhase 2
Testing QY201 tablets for non-segmental vitiligo
This trial tests an experimental oral tablet called QY201 to see if it can improve vitiligo (white patches on the skin). It is for adults with non-segmental vitiligo, regardless of whether the patches are currently growing or stable.
Shenyang, LiaoningAges 18–65 - NCT05714241Recruiting
Blood tests to study heart pain with blocked-unblocked arteries
This study looks at blood “biomarkers” and platelet function to better understand INOCA (heart-related chest pain despite no major artery blockage). You may be eligible if you have INOCA and are already taking aspirin, and if you haven’t taken certain blood-thinner or platelet-altering medicines recently.
RomeAges 18 years+ - NCT07519733Recruiting
Exercise Testing Before High-Risk Surgery
This study tests whether a simple exercise test before surgery can help doctors better predict and prevent complications in older adults undergoing major operations. You'll do a gentle exercise test on a stationary bike or treadmill to measure your fitness level.
New Haven, ConnecticutAges 45 years+ - NCT06295770RecruitingPhase 2
Obinutuzumab for fibrillary glomerulonephritis
This trial tests whether obinutuzumab, a targeted therapy that quiets certain immune cells, can reduce kidney damage in people with fibrillary glomerulonephritis. If you have this rare kidney condition and significant protein in your urine, this study may offer a new treatment option.
Rochester, MinnesotaAges 18 years+ - NCT06682117Recruiting
A study of a personalized vaccine for advanced solid tumors
This trial tests a personalized vaccine made from your own cells to help your immune system attack tumor-specific targets. It may be an option if standard treatments have stopped working or caused side effects you can't tolerate.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06398444RecruitingPhase 2/Phase 3
Lutetium-177 treatment for advanced neuroendocrine tumors
This trial tests a radioactive drug called Lutetium-177 Oxodotreotide (a type of PRRT) for people with advanced neuroendocrine tumors that have already been treated with other therapies and are still growing. The drug targets somatostatin receptors on tumor cells to deliver radiation directly to the cancer.
Shanghai, Shanghai MunicipalityAges 12 years+
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,572 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.